Schistosomiasis mansoni: Novel chemotherapy using a cysteine protease inhibitor

PLoS Medicine

Volumn 4, Issue 1, 2007, Pages 0130-0138

  Abdulla, Maha Hamadien ^a   Lim, Kee Chong ^a   Sajid, Mohammed ^a   McKerrow, James H ^a   Caffrey, Conor R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CATHEPSIN B; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; K 11777; PRAZIQUANTEL; SULFONE DERIVATIVE; UNCLASSIFIED DRUG; VINYL DERIVATIVE; CATHEPSIN; DIPEPTIDE; N PIP PHENYLALANINE HOMOPHENYLALANINE VINYL SULFONE PHENYL; N-PIP-PHENYLALANINE-HOMOPHENYLALANINE-VINYL SULFONE PHENYL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TARGETING; HEPATOMEGALY; LIVER FUNCTION; LIVER GRANULOMA; LUNG INFECTION; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PARASITE MIGRATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SKIN INFECTION; SPLENOMEGALY; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; LIVER; MALE; METABOLISM; OOCYTE; PARASITOLOGY; PATHOLOGY; SCHISTOSOMIASIS MANSONI; SNAIL; SPLEEN; TIME;

ANIMALS; CATHEPSINS; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; FEMALE; HEPATOMEGALY; LIVER; MALE; MICE; MICE, INBRED BALB C; OVUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SNAILS; SPLEEN; SPLENOMEGALY; TIME FACTORS; VINYL COMPOUNDS;

EID: 33846697738     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040014     Document Type: Article

References (48)

1. Savioli L, Albonico M, Engels D, Montresor A (2004) Progress in the prevention and control of schistosomiasis and soil-transmitted helminthiasis. Parasitol Int 53: 103-113.
2. Pearce EJ, MacDonald AS (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511.
3. Harder A (2002) Chemotherapeutic approaches to schistosomes: Current knowledge and outlook. Parasitol Res 88: 395-397.
4. Anonymous (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 912. 64 pp.
5. Sabah AA, Fletcher C, Webbe G, Doenhoff MJ (1986) Schistosoma mansoni: Chemotherapy of infections of different ages. Exp Parasitol 61: 294-303.
6. Utzinger J, Keiser J, Shuhua X, Tanner M, Singer BH (2003) Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47: 1487-1495.
7. Raso G, N'Goran EK, Toty A, Luginbuhl A, Adjoua CA, et al. (2004) Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Cote d'Ivoire. Trans R Soc Trop Med Hyg 98: 18-27.
8. Cioli D (2000) Praziquantel: Is there real resistance and are there alternatives? Curr Opin Infect Dis 13: 659-663.
9. Danso-Appiah A, De Vlas SJ (2002) Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol 18: 125-129.
10. Ismail M, Botros S, Metwally A, William S, Farghally A, et al. (1999) Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 60: 932-935.
11. Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51: 83-88.
12. McKerrow JH, Engel JC, Caffrey CR (1999) Cysteine protease inhibitors as chemotherapy for parasitic infections. Bioorg Med Chem 7: 639-644.
13. Sajid M, McKerrow JH (2002) Cysteine proteases of parasitic organisms. Mol Biochem Parasitol 120: 1-21.
14. Rosenthal PJ (2004) Cysteine proteases of malaria parasites. Int J Parasitol 34: 1489-1499.
15. Meirelles MN, Juliano L, Carmona E, Silva SG, Costa EM, et al. (1992) Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol Biochem Parasitol 52: 175-184.
16. Engel JC, Doyle PS, Hsieh I, McKerrow JH (1998) Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J Exp Med 188: 725-734.
17. Caffrey CR, Scory S, Steverding D (2000) Cysteine proteinases of trypanosome parasites: Novel targets for chemotherapy. Curr Drug Targets 1: 155-162.
18. Caffrey CR, McKerrow JH, Salter JP, Sajid M (2004) Blood 'n' guts: An update on schistosome digestive peptidases. Trends Parasitol 20: 241-248.
19. Wasilewski MM, Lim KC, Phillips J, McKerrow JH (1996) Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo. Mol Biochem Parasitol 81: 179-189.
20. McKerrow JH (2005) Designing drugs for parasitic diseases of the developing world. PLoS Med 2: doi:10.1371/journal.pmed.0020210
21. Barr SC, Warner KL, Kornreic BG, Piscitelli J, Wolfe A, et al. (2005) A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi. Antimicrob Agents Chemother 49: 5160-5161.
22. Smithers SR, Terry RJ (1965) The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55: 695-700.
23. Duvall RH, DeWitt WB (1967) An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 16: 483-486.
24. Cheever AW, Finkelman FD, Caspar P, Heiny S, Macedonia JG, et al. (1992) Treatment with anti-IL-2 antibodies reduces hepatic pathology and eosinophilia in Schistosoma mansoni-infected mice while selectively inhibiting T cell IL-5 production. J Immunol 148: 3244-3248.
25. Caffrey CR, Ruppel A (1997) Cathepsin B-like activity predominates over cathepsin L-like activity in adult Schistosoma mansoni and S. japonicum. Parasitol Res 83: 632-635.
26. Greenbaum D, Medzihradszky KF, Burlingame A, Bogyo M (2000) Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem Biol 7: 569-581.
27. Murata M, Miyashita S, Yokoo C, Tamai M, Hanada K, et al. (1991) Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Lett 280: 307-310.
28. Clegg JA (1965) In vitro cultivation of Schistosoma mansoni. Exp Parasitol 16: 133-147.
29. Rheinberg CE, Moné H, Caffrey CR, Imbert-Establet D, Jourdane J, et al. (1998) Schistosoma haematobium, S. intercalatum, S. japonicum, S. mansoni, and S. rodhaini in mice: Relationship between patterns of lung migration by schistosomula and perfusion recovery of adult worms. Parasitol Res 84: 338-342.
30. Loker ES (1983) A comparative study of the life-histories of mammalian schistosomes. Parasitology 87: 343-369.
31. Sajid M, McKerrow JH, Hansell E, Mathieu MA, Lucas KD, et al. (2003) Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. Mol Biochem Parasitol 131: 65-75.
32. Tort J, Brindley PJ, Knox D, Wolfe KH, Dalton JP (1999) Proteinases and associated genes of parasitic helminths. Adv Parasitol 43: 161-266.
33. Ambroso JL, Harris C (1994) In vitro embryotoxicity of the cysteine proteinase inhibitors benzyloxycarbonyl-phenylalanine-alanine-diazomethane (Z-Phe-Ala-CHN2) and benzyloxycarbonyl-phenylalanine-phenylalanine-diazomethane (Z-Phe-Phe-CHN2). Teratology 50: 214-228.
34. Eichhold TH, Hookfin EB, Taiwo YO, De B, Wehmeyer KR (1997) Isolation and quantification of fluoroacetate in rat tissues, following dosing of Z-Phe-Ala-CH2-F, a peptidyl fluoromethyl ketone protease inhibitor. J Pharm Biomed Anal 16: 459-467.
35. Powers JC, Asgian JL, Ekici OD, James KE (2002) Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem Rev 102: 4639-4750.
36. Jacobsen W, Christians U, Benet LZ (2000) In vitro evaluation of the disposition of a novel cysteine protease inhibitor. Drug Metab Dispos 28: 1343-1351.
37. Brömme D, Klaus JL, Okamoto K, Rasnick D, Palmer JT (1996) Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem J 315: 85-89.
38. Palmer JT, Rasnick D, Klaus JL, Brömme D (1995) Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem 38: 3193-3196.
39. Rosenthal PJ, Olson JE, Lee GK, Palmer JT, Klaus JL, et al. (1996) Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob Agents Chemother 40: 1600-1603.
40. Delcroix M, Sajid M, Caffrey CR, Lim KC, Dvorák J, et al. (2006) A multienzyme network functions in intestinal protein digestion by a platyhelminth parasite. Biol Chem. Epub ahead of print 6 October 2006.
41. Correnti JM, Brindley PJ, Pearce EJ (2005) Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol 143: 209-215.
42. Skelly PJ, Da'dara A, Harn DA (2003) Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Int J Parasitol 33: 363-369.
43. Xiao SH (2005) Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop 96: 153-167.
44. Xiao SH, Catto BA (1989) In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother 33: 1557-1562.
45. Zerda KS, Dresden MH, Chappell CL (1988) Schistosoma mansoni: Expression and role of cysteine proteinases in developing schistosomula. Exp Parasitol 67: 238-246.
46. Cesari IM, Rodriguez M, McLaren DJ (1981) Proteolytic enzymes in adult male and female worms of Schistosoma mansoni. Acta Cient Venez 32: 324-329.
47. Dresden MH, Payne DC, Basch PF (1982) Acidic thiol proteinase activity of Schistosoma mansoni cultured in vitro. Mol Biochem Parasitol 6: 203-208.
48. Lawrence JD (1973) The ingestion of red blood cells by Schistosoma mansoni. J Parasitol 59: 60-63.